2020-2024
Horníková L., Henke P., Kubát P., Mosinger J. (2024): Specifically targeting capture and photoinactivation of viruses through phosphatidylcholine-ganglioside vesicles with photosensitizer. JACS Au, doi:10.1021.jacsau.4c00453 [ACS Publications]
Vráblíková A., Brezani V., Pšíkal I., Fraiberk M., Šebela M, Fojtíková M., Kulich P., Hezová R., Mašek J. (2023): Development of modern immunization agent against bovine papillomavirus type 1 infection based on BPV1 L1 recombinant protein. Front. Vet. Sci. 10: 1116661. [PubMed]
Vráblíková A., Fojtíková M., Hezová R, Šimečková P., Brezani V., Straková N., Fraiberk M., Kotouček J., Mašek J., Pšíkal I. (2023): UV-C irradiation as an effective tool for sterilization of porcine chimeric VP1-PCV2bCap recombinant vaccine. Sci. Rep. 13 (1): 19337. [PubMed]
Hejtmánková A., Caisová H., Tomanová T., Španielová H. (2023): The role of the DE and EF loop of BKPyV VP1 in the serological cross-reactivity between subtypes. Virus Res. 324: 199031. [PubMed]
Ryabchenko B., Šroller V., Horníková L., Lovtsov A., Forstová J., Huérfano S. (2023): The interactions between PML nuclear bodies and small and medium size DNA viruses. Virol. J. 20 (1): 82. [PubMed]
Španielová H., Brdička R. (2023): Oncolytic viruses and cancer treatment. Klin. Onkol. 36 (1): 12-27. [PubMed]
Bates E.A., Davies J.A., Váňová J., Nestic D., Meniel V.S., Koushyar S., Cunliffe T.G., Mundy R.M., Moses E., Uusi-Kerttula H.K., Baker A.T., Cole D.K., Majhen D., Rizkallah P.J., Phesse T., Chester J.D., Parker A.L. (2022): Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10. Mol. Ther.-Oncolytics 25: 43-56. [PubMed]
Horníková L., Bruštíková K., Huérfano S., Forstová J. (2022): Nuclear cytoskeleton in virus infection. Int. J. Mol. Sci. 23 (1): 578. [PubMed]
Huérfano Meneses S., Šroller V., Bruštíková K., Horníková L., Forstová J. (2022): The interplay between viruses and host DNA sensors. Viruses-Basel 14 (4): 666. [PubMed]
Saláková M., Ludvíková V., Hamšíková E., Kolářová M., Šroller V., Viklický O., Wohlfahrtová M. (2022): Pretransplantation seroreactivity in kidney donors and recipients as a predictive factor for posttransplant BKPyV-DNAemia. Front Immunol. 13: 929946. [PubMed]
Váňová J., Číhařová B., Hejtmánková A., Epperla C.P., Škvára P., Forstová J., Hubálek Kalbáčová M., Španielová H. (2022): VirPorters: Insights into the action of cationic and histidine-rich cell-penetrating peptides. Int. J. Pharm. 611: 121308. [PubMed]
Hejtmánková A., Váňová J., Španielová H. (2021): Cell-penetrating peptides in the intracellular delivery of viral nanoparticles. In: Litwack G. (ed.): Vitamins and Hormones 117,Academic Press/Elsevier, Cambridge, MA-San Diego, CA-Oxford-London, pp. 47-76. [PubMed]
Janovec V., Ryabchenko B., Škarková A., Pokorná K., Rösel D., Brábek J., Weber J., Forstová J., Hirsch I., Huérfano S. (2021): TLR4-mediated recognition of mouse polyomavirus promotes cancer-associated fibroblast-like phenotype and cell invasiveness. Cancers 13 (9): 2076. [PubMed]
Kaštánková I., Štach M., Žižková H., Ptáčková P., Šmilauerová K., Mucha M., Šroller V., Otáhal P. (2021): Enzymatically produced piggyBac transposon vectors for efficient non-viral manufacturing of CD19-specific CAR T cells. Mol. Ther.-Methods Clin. Dev. 23: 119-127. [PubMed]
Lubyová B., Tikalová E., Krulová K., Hodek J., Zábranský A., Hirsch I., Weber J. (2021): ATM-dependent phosphorylation of hepatitis B core protein in response to genotoxic stress. Viruses-Basel 13 (12): 2438. [PubMed]
Oliver-Guimerá A., Hejtmánková A., Jackson K., Pesavento P.A. (2021): A polyomavirus detected in American black bear (Ursus americanus). Arch. Virol. 166 (5): 1521-1524. [PubMed]
Ryabchenko B., Soldatova I., Šroller V., Forstová J., Huérfano S. (2021): Immune sensing of mouse polyomavirus DNA by p204 and cGAS DNA sensors. FEBS J. 288 (20): 5964-5985 [PubMed]
Šťastná-Marková M., Hamšíková E., Hainz P., Hubáček P., Kroutilová M., Kryštofová J., Ludvíková V., Musil J., Pecherková P., Saláková M., Šroller V., Vydra J., Němečková Š. (2021): Pretransplant BK virus-specific T-cell-mediated immunity and serotype specific antibodies may have utility in identifying patients at risk for BK virus-associated haemorrhagic cystitis after allogeneic HSCT. Vaccines 9 (11): 1226 [PubMed]
Vonka V., Hirsch I. (2021): Prophylactic vaccines against cancers of non-infectious origin: a dream or a real possibility? Cent. Eur. J. Public Health 29 (4): 247-258. [PubMed]
Horníková L., Bruštíková K., Forstová J. (2020): Microtubules in polyomavirus infection. Viruses-Basel 12 (1): 121. [PubMed]
Horníková L., Bruštíková K., Ryabchenko B., Zhernov I., Fraiberk M., Mariničová Z., Lánský Z., Forstová J. (2020): The major capsid protein, VP1, of the mouse polyomavirus stimulates the activity of tubulin acetyltransferase 1 by microtubule stabilization. Viruses-Basel 12 (2): 227. [PubMed]
Janovec V., Hodek J., Clarová K., Hofman T., Dostalík P., Froněk J., Chlupáč J., Chaperot L., Durand S., Baumert T.F., Pichová I., Lubyová B., Hirsch I., Weber J. (2020): Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced cytokines that inhibit hepatitis B virus production in primary human hepatocytes. Sci. Rep. 10 (1): 12767. [PubMed]
Langerová H., Lubyová B., Zábranský A., Hubálek M., Glendová K., Aillot L., Hodek J., Strunin D., Janovec V., Hirsch I., Weber J. (2020): Hepatitis B core protein is post-translationally modified through K29-linked ubiquitination. Cells 9 (12): 2547. [PubMed]
Maléřová S., Hejtmánková A., Hamšíková E., Saláková M., Šmahelová J., Klozar J., Tachezy R. (2020): Prevalence and risk factors for oral HPV in healthy population, in central Europe. Anticancer Res. 40 (3): 1597-1604. [PubMed]
Váňová J., Hejtmánková A., Žáčková Suchanová J., Sauerová P., Forstová J., Kalbáčová M.H., Španielová H. (2020): Influence of cell-penetrating peptides on the activity and stability of virus-based nanoparticles. Int. J. Pharm. 576: 119008 [PubMed]
Žáčková Suchanová J., Hejtmánková A., Nebůrková J., Cígler P., Forstová J., Španielová H. (2020): The protein corona does not influence receptor-mediated targeting of virus-like particles. Bioconjug. Chem. 31 (5): 1575-1585. [PubMed]
2015-2019
Hejtmánková A., Roubalová K., Forejtová A., Žáčková Suchanová J., Forstová J., Viklický O., Španielová H. (2019): Prevalence of antibodies against BKPyV subtype I and IV in kidney transplant recipients and in the general Czech population. J. Med. Virol. 91 (5): 856-864. [PubMed]
Váňová J., Hejtmánková A., Kalbáčová M.H., Španielová H. (2019): The utilization of cell-penetrating peptides in the intracellular delivery of viral nanoparticles. Materials 12 (17): E2671. [PubMed]
Font-Haro A., Janovec V., Hofman T., Machala L., Jilich D., Mělková Z., Weber J., Trejbalová K., Hirsch I. (2018): Expression of TIM-3 on plasmacytoid dendritic cells as a predictive biomarker of decline in HIV-1 RNA level during ART. Viruses-Basel 10 (4): 154. [PubMed]
Janovec V., Aouar B., Font-Haro A., Hofman T., Trejbalová K., Weber J., Chaperot L., Plumas J., Olive D., Dubreil P., Nunés J.A., Stránská R., Hirsch I. (2018): The MEK1/2-ERK pathway inhibits Type I IFN production in plasmacytoid dendritic cells. Front. Immunol. 9: 364. [PubMed]
Nebůrková J., Sedlák F., Žáčková Suchanová J., Kostka L., Sacha P., Subr V., Etrych T., Simon P., Barinková J., Kryštůfek R., Španielová H., Forstová J., Konvalinka J., Cígler P. (2018): Inhibitor-GCPII interaction: Selective and robust system for targeting cancer cells with structurally diverse nanoparticles. Mol. Pharmaceut. 15 (8): 2932-2945 [PubMed]
Soldatova I., Prilepskaja T., Abrahamyan L., Forstová J., Huérfano S. (2018): Interaction of the mouse polyomavirus capsid proteins with importins is required for efficient import of viral DNA into the cell nucleus. Viruses-Basel 10 (4): 165. [PubMed]
Verrier E.R., Yim S.A., Heydmann L., El Saqhire H., Bach C., Turon-Laqot V., Mailly L., Durand S.C., Lucifora J., Durantel D., Pessaux P., Manel N., Hirsch I., Zeisel M.B., Pochet N., Schuster C., Baumert T.F. (2018): Hepatitis B virus evasion from cGAS sensing in human hepatocytes. Hepatology 68 (5): 1695-1709. [PubMed]
Fraiberk M., Hájková M., Krulová M., Kojzarová M., Drda Morávková A., Pšikal I., Forstová J. (2017): Exploitation of stable nanostructures based on the mouse polyomavirus for development of a recombinant vaccine against porcine circovirus 2. PLoS ONE 12 (9): e0184870. [PubMed]
Hirsch I., Janovec V., Stránská R., Bendriss-Vermare N. (2017): Cross talk between inhibitory immunoreceptor tyrosine-based activation motif-signaling and Toll-like receptor pathways in macrophages and dendritic cells. Front. Immunol. 8: 394. [PubMed]
Horníková L.., Fraiberk M., Man P., Janovec V., Forstová J. (2017): VP1, the major capsid protein of the mouse polyomavirus, binds microtubules, promotes their acetylation and blocks the host cell cycle. FEBS J. 284 (2): 301-323. [PubMed]
Huérfano S., Ryabchenko B., Španielová H., Forstová J. (2017): Hydrophobic domains of mouse polyomavirus minor capsid proteins promote membrane association and virus exit from the ER. FEBS J. 284 (6): 883-902. [PubMed]
Lubyová B., Hodek J., Zábranský A., Prouzová H., Hubálek M., Hirsch I., Weber J. (2017): PRMT5: A novel regulator of Hepatitis B virus replication and an arginine methylase of HBV core. PLoS ONE 2 (10): e0186982. [PubMed]
Žáčková Suchanová J., Nebůrková J., Španielová H., Forstová J., Cigler P. (2017): Retargeting polyomavirus-like particles to cancer cells by chemical modification of capsid surface. Bioconjugate Chem. 28 (2): 307–313. [PubMed]
Aouar B., Kovářová D., Letard S., Font-Haro A., Florentin J., Weber J., Durantel D., Chaperot L., Plumas J., Trejbalová K., Hejnar J., Nunès J.A., Olive D., Dubreuil P., Hirsch I., Stránská R. (2016): Dual role of the tyrosine kinase Syk inregulation of Toll-like receptor signaling in plasmacytoid dendritic cells. PLoS One 11 (6): e0156063. [PubMed]
Henke P., Kirakci K., Kubát P., Fraiberk M., Forstová J., Mosinger J. (2016): Antibacterial, antiviral, and oxygen-sensing nanoparticles prepared from electrospun materials. ACS Appl. Mater. Interfaces 8 (38): 25127–25136. [PubMed]
Němečková Š., Kryštofová J., Babiarová K., Hainz P., Musil J., Šroller V., Malý M., Šťastná-Marková M. (2016): Reconstitution of cytomegalovirus-specific T-cell response in allogeneic hematopoietic stem cell recipients: the contribution of six frequently recognized, virus-encoded ORFs. Transpl. Infect. Dis. 18 (3): 381-389. [PubMed]
Němečková Š., Šroller V., Šťastná-Marková M. (2016): Evolution of human cytomegalovirus-seronegative donor/-seropositive recipient high-risk combination frequency in allogeneic hematopoietic stem cell transplantations at Institute of Hematology and Blood Transfusion during 1995-2014. Transpl. Infect. Dis. 18 (2): 297-301. [PubMed]
Saláková M., Košlabová E., Vojtěchová Z., Tachezy R., Šroller V. (2016): Detection of human polyomaviruses MCPyV, HPyV6, and HPyV7 in malignant and non-malignant tonsillar tissues. J. Med. Virol. 88 (4): 695-702. [PubMed]
Šroller V., Hamšíková E., Ludvíková V., Musil J., Němečková Š., Saláková M. (2016): Seroprevalence rates of HPyV6, HPyV7, TSPyV, HPyV9, MWPyV and KIPyV polyomaviruses among the healthy blood donors. J. Med. Virol. 88 (7): 1254-1261. [PubMed]
Suchanová J., Španielová H., Forstová J. (2016): Applications of viral particles based on polyomavirus and papillomavirus structures. In: Khudyakov Y., Pumpens P. (eds): Viral Nanotechnology, CRC Press, Boca Raton (FL), pp. 303-362. [Taylor and Francis]
Trejbalová K., Kovářová D., Blažková J., Machala L., Jilich D., Weber J., Kučerová D., Vencálek O., Hirsch I., Hejnar J. (2016): Development of 5' LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individuals. Clin. Epigenetics 8: 19. [PubMed]
Saláková M., Košlabová E., Vojtěchová Z., Tachezy R., Šroller V. (2015): Detection of human polyomaviruses MCPyV, HPyV6, and HPyV7 in malignant and non-malignant tonsillar tissues. J. Med. Virol. 88 (4): 695-702. [Pubmed]
Horníková L., Žíla V., Španielová H., Forstová J. (2015): Mouse polyomavirus: propagation, purification, quantification, and storage. Curr. Protoc. Microbiol. 38: 14F.1.1-14F.1.26. [PubMed]
2010-2014
Bílková E., Forstová J., Abrahamyan L. (2014): Coat as the dagger: the use of capsid proteins to perforate membranes during non-enveloped DNA viruses trafficking. Viruses 6 (7): 2899-2937. [PubMed]
Henke P., Kozak H., Artemenko A., Kubát P., Forstová J., Mosinger J. (2014): Superhydrophilic polystyrene nanofiber materials generating O2(1deltag): postprocessing surface modifications toward efficient antibacterial effect. ACS Appl. Mater. Interfaces 6 (15): 13007-13014. [PubMed]
Kletetschka G., Žíla V., Klímová L. (2014): Efficiency of cellular growth when creating small pockets of electric current along the walls of cells. Rejuv. Res. 17 (2): 226-228. [PubMed]
Španielová H., Fraiberk M., Suchanová J., Soukup J., Forstová J. (2014): The encapsidation of polyomavirus is not defined by a sequence-specific encapsidation signal. Virology 450-451: 122-131. [PubMed]
Šroller V., Hamšíková E., Ludvíková V., Vochozková P., Kojzarová M., Fraiberk M., Saláková M., Morávková A., Forstová J., Němečková Š. (2014): Seroprevalence rates of BKV, JCV, and MCPyV polyomaviruses in the general Czech Republic population. J. Med. Virol. 86 (9): 1560-1568. [PubMed]
Žíla V., Difato F., Klímová L., Huerfano S, Forstová J. (2014): Involvement of microtubular network and its motors in productive endocytic trafficking of mouse polyomavirus. PLoS ONE 9 (5): e96922. [PubMed]
Hron T., Španielová H., Suchanová J., Forstová J. (2013): The Cre/loxP recombination system for production of infectious mouse polyomavirus. Virus Res. 176 (1-2): 128-136. [PubMed]
Huerfano S., Ryabchenko B., Forstová J. (2013): Nucleofection of expression vectors induces a robust interferon response and inhibition of cell proliferation. DNA Cell Biol. 32 (8): 467-479. [PubMed]
Cibulka J., Fraiberk M., Forstová J. (2012): Nuclear actin and lamins in viral infections. Viruses-Basel 4 (3): 325-345. [PubMed]
Lhotáková Y., Plíštíl L., Morávková A., Kubát P., Lang K., Forstová J., Mosinger J. (2012): Virucidal nanofiber textiles based on photosensitized production of singlet oxygen. PLoS ONE 7 (11): e49226. [PubMed]
Horníková L., Man P., Forstová J. (2011): Blue native protein electrophoresis for studies of mouse polyomavirus morphogenesis and interactions between the major capsid protein VP1 and cellular proteins. J. Virol. Methods 178 (1-2): 229-234. [PubMed]
Smirnov E., Cmarko D., Kováčik L., Hagen G.M., Popov A., Raška O., Prieto J.L., Ryabchenko B., Amim F., McStay B., Raška I. (2011): Replication timing of pseudo-NORs. J. Struct. Biol. 173 (2): 213-218. [PubMed]
Zhou A.Y., Ichaso N., Adamarek A., Žíla V., Forstová J., Dibb N.J., Dilworth S.M. (2011): Polyomavirus middle T-antigen is a transmembrane protein that binds signalling proteins in discrete subcellular membrane sites. J. Virol. 85 (7): 3046-3054. [PubMed]
Huerfano S., Žíla V., Bouřa E., Španielová H., Štokrová J., Forstová J. (2010): Minor capsid proteins of mouse polyomavirus are inducers of apoptosis when produced individually but are only moderate contributors to cell death during the late phase of viral infection. FEBS J. 277 (5): 1270-1283. [PubMed]
Kořínková T., Morávková A. (2010): Does polyploidy occur in central European species of the family Sphaeridae (Mollusca: Bivalvia)? Centr. Eur. J. Biol. 5 (6): 777-784. [SpringerLink]
2005-2009
Hrušková V., Morávková A., Babiarová K., Ludvíková V., Frič J., Vonka V., Forstová J. (2009): Bcr-Abl fusion sequences do not induce immune responses in mice when administered in mouse polyomavirus based virus-like particles. Int. J. Oncol. 35 (6): 1247-1256. [PubMed]
Frič J., Marek M., Hrušková V., Holáň V., Forstová J. (2008): Cellular and humoral immune responses to chimeric EGFP-pseudocapsids derived from the mouse polyomavirus after their intranasal administration. Vaccine 26 (26): 3242-3251. [PubMed]
Roitman-Shemer V., Štokrová J., Forstová J., Oppenheim A. (2007): Assemblages of simian virus 40 capsid proteins and viral DNA visualized by electron microscopy. Biochem. Biophys. Res. Commun. 353 (2): 424-430. [PubMed]
Žurmanová J., Difato F., Maláčová D., Mejsnar J., Štefl B., Zahradník I. (2007): Creatine kinase binds more firmly to the M-band of rabbit skeletal muscle myofibrils in the presence of its substrates. Mol. Cell. Biochem. 305 (1-2): 55-61. [PubMed]
Liebl D., Difato F., Horníková L., Mannová P., Štokrová J., Forstová J. (2006): Mouse polyomavirus enters early endosomes, requires their acidic pH for productive infection, and meets transferrin cargo in Rab11-positive endosomes. J. Virol. 80 (9): 4610-4622. [PubMed]
Adamec T., Palková Z., Velková K., Štokrová J., Forstová J. (2005): Point mutation in calcium-binding domain of mouse polyomavirus VP1 protein does not prevent virus-like particle formation, but changes VP1 interactions with Saccharomyces cerevisiae cell structures. FEMS Yeast Res. 5 (4-5): 331-340. [PubMed]
Bouřa E., Liebl D., Spíšek R., Frič J., Marek M., Štokrová J., Holan V., Forstová J. (2005): Polyomavirus EGFP-pseudocapsids: Analysis of model particles for introduction of proteins and peptides into mammalian cells. FEBS Lett. 579 (29): 6549-6558. [PubMed]
Franzén Vlastos A., Tegerstedt K., Hollanderová D., Forstová J., Ramqvist T., Dalianis T. (2005): Murine polyomavirus-VP1 virus-like particles immunize against some polyomavirus-induced tumours. In Vivo 19 (2): 323-326. [PubMed]
Morávková A., Málek O., Pokorná E., Strnádel J., Hradecký J., Horák V. (2005): Immune characterization of the Lewis rats inoculated with K2 sarcoma cell line and newly derived R5-28 malignant cells. Folia Biol. (Prague) 51 (6): 159-165. [PubMed]
2000-2004
Pappová M., Stančeková M., Spiššáková I., Ďurmanová V., Mistríková J. (2004): Pathogenetical characterization of isolate MHV-60 of mouse herpesvirus strain 68. Acta Virol. 48 (2): 91-96. [PubMed]
Sun J., Sinkora J., Wertz N., Morávková A., Butler J. (2004): Characterization of porcine CD19 and anti-CD19 monoclonal antibodies. Mol. Immunol. 41 (9): 929-938. [PubMed]
Adamec T., Palková Z., Forstová J. (2003): Mouse polyomavirus large T antigen inhibits cell growth and alters cell and colony morphology in Saccharomyces cerevisiae. FEBS Lett. 555 (2): 268-273. [PubMed]
Faldyna M., Sinkora J., Knotigová P., Řeháková Z., Morávková A., Toman M. (2003): Flow cytometric analysis of bone marow leucocytes in neonatal dogs. Vet. Immunol. Immunopathol. 95 (3-4): 165-176. [PubMed]
Forstová J., Griffin B.E., Krauzewicz N.S. (2003): Papovavirus pseudocapsids and use thereof for exogenous material transfer (patent). US Patent No. 6613749.
Hollanderová D., Rašlová H., Blangy D., Forstová J., Berrebi M. (2003): Interference of mouse polyomavirus with c-myc gene and its product in mouse mammary adenocarcinomas. Int. J. Oncol. 23 (2): 333-341. [PubMed]
Mannová P., Forstová J. (2003): Mouse polyomavirus utilizes recycling endosomes for a traffic pathway independent of COP1 vesicle transport. J. Virol. 77 (3): 1672-1681. [PubMed]
Mrmusová-Šupolíková M., Pappová M., Mistríková J. (2003): Pathogenesis of murine lymphotropic gammaherpesvirus isolate 78. Acta Veterinaria Brno 72 (3): 371-376. [Acta Veterinaria Brno]
Vlastos A., Andreasson K., Hollanderová D., Heidari S., Forstová J., Ramqvist T., Dalianis T. (2003): VP1 pseudocapsids, but not a glutathione-S-transferase VP1 fusion protein, prevent polyomavirus infection in a T-cell immune deficient experimental mouse model. J. Med. Virol. 70 (2): 293-300. [PubMed]
Mannová P., Liebl D., Krauzewicz N., Fejtová A., Štokrová J., Palková Z., Griffin B.E., Forstová J. (2002): Analysis of mouse polyomavirus mutants with lesions in the minor capsid proteins. J. Gen. Virol. 83 (9): 2309-2319. [PubMed]
Španielová H. (2002): Analysis of regulation of polyomavirus promoters by a luciferase reporter system. Acta Virol. 46 (4): 219-227. [PubMed]
Zikánová B., Kuthan M., Řičicová M., Forstová J., Palková Z. (2002): Amino acids control ammonia pulses in yeast cell colonies. Biochem. Biophys. Res. Commun. 294 (5): 962-967. [PubMed]
Mináriková L., Kuthan M., Řičicová M., Forstová J., Palková Z. (2001): Differentiated gene expression in cells within yeast colonies. Exp. Cell Res. 271 (2): 296-304. [PubMed]
Richterová Z., Liebl D., Horák M., Palková Z., Štokrová J., Hozák P., Korb J., Forstová J. (2001): Caveolae are involved in the trafficking of mouse polyomavirus virions and artificial VP1 pseudocapsids towards cell nuclei. J. Virol. 75 (22): 10880-10891. [PubMed]
Španielová H., Velková K. (2001): The cellular nuclear matrix regulatory protein YY1 does not directly interact with the mouse polyomavirus large tumor antigen. Acta Virol. 45 (3): 191-195. [PubMed]
Forstová J., Griffin B.E., Krauzewicz N.S. (2000): Polyoma virus pseudocapsids and method to deliver material into cell (patent). US Patent No. 6046173.
Palková Z., Adamec T., Liebl D., Štokrová J., Forstová J. (2000): Production of polyomavirus structural protein VP1 in yeast cells and its interactions with cell structures. FEBS Lett. 478 (3): 281-289. [PubMed]
Palková Z., Forstová J. (2000): Yeast colonies synchronise their growth and development. J. Cell Sci. 113 (11): 1923-1928. [PubMed]
Palková Z., Španielová H., Gottifredi V., Hollanderová D., Forstová J., Amati P. (2000): The polyomavirus major capsid protein VP1 interacts with the host nuclear matrix regulatory protein YY1. FEBS Lett. 467 (2-3): 359-364. [PubMed]
1995-1999
Štokrová J., Palková Z., Fischer L., Richterová Z., Korb J., Griffin B.E., Forstová J. (1999): Interactions of heterologous DNA with polyomavirus major structural protein, VP1. FEBS Lett. 445 (1): 119-125. [PubMed]
Soeda E., Krauzewicz N., Cox C., Štokrová J., Forstová J., Griffin B.E. (1998): Enhancement by polylysin of transient, but not stable expression of genes carried into cells by polyoma VP1 pseudocapsids. Gene Ther. 5 (10): 1410-1419. [PubMed]
Palková Z., Janderová B., Gabriel J., Zikánová B., Pospíšek M., Forstová J. (1997): Ammonia mediates communication between yeast colonies. Nature 390 (6659): 532-536. [PubMed]
Štokrová J., Korb J., Palková Z., Fischer L., Forstová J. (1996): Interaction of artificially prepared polyoma virus-like particles with heterologous DNA. J. Computer Assist. Microsc. 8: 211-212.
Forstová J., Krauzewicz N., Sandig V., Elliot J., Palková Z., Strauss M., Griffin B.E. (1995): Polyoma virus pseudocapsids as efficient carriers of heterologous DNA into mammalian cells. Hum. Gene Ther. 6 (3): 297-306.[PubMed]
Preprint servers
Vráblíková A., Fojtíková M., Fraiberk M., Kotouček J., Kulich P., Brezani V., Gebauer J., Novobilský A., Mašková E., Zechmeisterová K., Straková N., Mašek J., Pšíkal I., Hezová R. (2022): Development of modern immunizing agent against porcine circovirus type 2 infection based on chimeric VP1-PCV2bCap recombinant protein. doi: 10.21203/rs.3.rs-2263216/v1 [ResearchSquare]
Publications only in Czech language are excluded from this list.